CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes - PubMed (original) (raw)
Review
CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes
A Bhushan et al. Immunol Res. 2001.
Abstract
Hyper-IgM (HIM) syndrome is a rare immunodeficiency characterized by low or absent IgG, IgA, and IgE with normal or elevated levels of IgM. This disorder can be acquired or familial with either X-linked or autosomal patterns of inheritance. The X-linked form of the disease is a consequence of mutations in the CD40 ligand (CD40L) gene that encodes a protein expressed primarily on activated CD4+ T cells. The cognate interaction between CD40L on T cells and CD40 on antigen-stimulated B cells, macrophage, and dendritic cells is critical for the development of a comprehensive immune response. The non-X-linked form of HIM syndrome is heterogeneous and appears in some cases to be a consequence of mutations in the AlD gene which encodes a B cell specific protein required for class switch recombination, somatic mutation, and germinal center formation. However, mutations in other unidentified genes are clearly the basis of the disease in a subset of patients. In this article, we review the essential features of the X-linked and non-X-linked forms of HIM syndrome and discuss the critical role the CD40:CD40L receptor-ligand pair plays in the pathogenesis of these immune deficiencies.
Similar articles
- CD40 ligand and its role in X-linked hyper-IgM syndrome.
Callard RE, Armitage RJ, Fanslow WC, Spriggs MK. Callard RE, et al. Immunol Today. 1993 Nov;14(11):559-64. doi: 10.1016/0167-5699(93)90188-Q. Immunol Today. 1993. PMID: 7506037 Review. - Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
Saiki O, Tanaka T, Wada Y, Uda H, Inoue A, Katada Y, Izeki M, Iwata M, Nunoi H, Matsuda I, et al. Saiki O, et al. J Clin Invest. 1995 Feb;95(2):510-4. doi: 10.1172/JCI117692. J Clin Invest. 1995. PMID: 7532185 Free PMC article. - Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
Van Hoeyveld E, Zhang PX, De Boeck K, Fuleihan R, Bossuyt X. Van Hoeyveld E, et al. Immunology. 2007 Apr;120(4):497-501. doi: 10.1111/j.1365-2567.2006.02520.x. Epub 2007 Jan 17. Immunology. 2007. PMID: 17244160 Free PMC article. - Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features.
Lougaris V, Badolato R, Ferrari S, Plebani A. Lougaris V, et al. Immunol Rev. 2005 Feb;203:48-66. doi: 10.1111/j.0105-2896.2005.00229.x. Immunol Rev. 2005. PMID: 15661021 Review.
Cited by
- Genetic characteristics of common variable immunodeficiency patients with autoimmunity.
Liu Z, Lu C, Qing P, Cheng R, Li Y, Guo X, Chen Y, Ying Z, Yu H, Liu Y. Liu Z, et al. Front Genet. 2023 Nov 13;14:1209988. doi: 10.3389/fgene.2023.1209988. eCollection 2023. Front Genet. 2023. PMID: 38028622 Free PMC article. - Male Sex Bias in Immune Biomarkers for Tuberculosis.
Bothamley GH. Bothamley GH. Front Immunol. 2021 Mar 16;12:640903. doi: 10.3389/fimmu.2021.640903. eCollection 2021. Front Immunol. 2021. PMID: 33796106 Free PMC article. - Mitochondrial DNA insert into CD40 ligand gene-associated X-linked hyper-IgM syndrome.
Li X, Xu D, Cheng B, Zhou Y, Chen Z, Wang Y. Li X, et al. Mol Genet Genomic Med. 2021 May;9(5):e1646. doi: 10.1002/mgg3.1646. Epub 2021 Mar 24. Mol Genet Genomic Med. 2021. PMID: 33764006 Free PMC article. - Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency.
Edwards ESJ, Bosco JJ, Ojaimi S, O'Hehir RE, van Zelm MC. Edwards ESJ, et al. Cell Mol Immunol. 2021 Mar;18(3):588-603. doi: 10.1038/s41423-020-00520-8. Epub 2020 Aug 17. Cell Mol Immunol. 2021. PMID: 32801365 Free PMC article. Review. - Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab.
Ridolo E, Pucciarini F, Nizi MC, Makri E, Kihlgren P, Panella L, Incorvaia C. Ridolo E, et al. Hum Vaccin Immunother. 2020 Oct 2;16(10):2349-2356. doi: 10.1080/21645515.2020.1753440. Epub 2020 May 13. Hum Vaccin Immunother. 2020. PMID: 32401603 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9437-42 - PubMed
- Immunity. 1996 Mar;4(3):263-73 - PubMed
- Curr Opin Immunol. 1996 Apr;8(2):199-205 - PubMed
- Annu Rev Immunol. 1996;14:591-617 - PubMed
- J Biol Chem. 1994 Dec 2;269(48):30069-72 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous